Tracy Høeg, MD, PhD (CAE) “Cardiac Adverse Event” - Hold off on definitively recommending vaccination of low-risk children against COVID-19

https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1.full.pdf

Tracy Høeg, MD, PhD
@TracyBethHoeg

(CAE) “Cardiac Adverse Event”

In light of the vaccine-associated cardiac harms described in this report, further research as well as transparency about possible vaccine-related harms in relation to an individual child’s COVID-19 risks is indicated.

Alternate vaccination types, dosingor strategies, such as those that take a history of infection into consideration,may eventually be found to be more appropriate in this age group.

Conclusion

Our report found post-vaccination CAE rates following dose two of 162.2 and 94.0/million for boys 12-15 and 16-17,respectively.

For boys with no underlying health conditions, the chance of either CAE, or hospitalization for CAE,after their second dose of mRNA vaccination are considerably higher than their 120-day risk of COVID-19 hospitalization, even at times of peak disease prevalence.

The long-term consequences of this vaccine-associated cardiac inflammation are not yet fully defined and should be studied.

In lieu of pediatric vaccination mandates, the US may:

1) consider gathering data on previous infection in this age group and/or

2) follow the example of

Germany, [31]
Sweden [32],
Norway [33] and
the WHO [34]

and hold off on definitively recommending vaccination of low-risk children against COVID-19, or

3) offer one dose to adolescents as the UK has just announced [35] while more information about risks, benefits, harms and alternative dosing or vaccination strategies are studied and considered.